From: Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
Gene | Chromosome | Cellular process and mechanism | In vitro | In vivo | Cancer type | Reference |
---|---|---|---|---|---|---|
ARID1A | 1p36.11 | Target SWI/SNF complexes, which regulate chromatin remodeling. SWI/SNF complexes are involved in controlling the cell cycle, DNA replication, and repairing DNA damage. | H1299, H2023, H2030 | Smarca4-deficient genetically engineered mouse | Lung cancer | [34] |
ATM | 11q22.3 | Activates cell cycle checkpoints; recognizes damaged DNA and triggers ATM-mediated DNA damage response pathway to repair damaged DNA strands. | KC (850, 6059, 8878), AKC (995, 5615, 5980, 5982) | AKC, KC, and SCID mouse | Pancreatic cancer | [35] |
ATR | 3q23 | Cell cycle checkpoint signaling activation upon DNA stress and triggers ATR-mediated DNA damage sensing. | Human-derived CLL and Mec1 cell line | Primary CLL xenograft mouse | Leukemia | |
BRCA1 | 17q21.31 | Repair DNA double-strand breaks via ubiquitination, transcriptional regulation, and homologous recombination. | A2780, HEK293, SUM149PT | N/A | Ovarian cancer | [38] |
BRCA2 | 13q13.1 | Repair DNA double-strand breaks via ubiquitination, transcriptional regulation, and homologous recombination. | PL2F7, Y3308Y | BRCA-deficient mouse | N/A | [39] |
CDC6 | 17q21.2 | Initiation of DNA replication; regulates cell cycle. | HCT-116, HKE-3 | KRAS-induced lung cancer mouse | Lung cancer | |
CDK1 | 10q21.2 | Regulate cell cycle (G1/S and G2/M phase transitions). | LIM1215, SW48 | KRAS-mutated mouse | N/A | [42] |
CDK2 | 12q13.2 | Regulate cell cycle (G1/S phase transition). | HACAT | N/A | N/A | |
CDK17 | 12q23.1 | Serine-threonine protein kinase; regulate G2/M phase transition. | HeLa, K562, MCF10A, MDA-MB-231, RPE1 | N/A | Breast cancer | [45] |
CHEK1 | 11q24.2 | Serine-threonine protein kinase; triggers cell cycle arrest in response to DNA damage; integrate signals from ATR and ATM; phosphorylation of CDC25A to delay cell cycle progression following DNA double-strand breaks. | PEO14, PEO23, SKOV3 | SKOV3 xenograft mouse | Ovarian cancer | [46] |
CHEK2 | 22q12.1 | Serine-threonine protein kinase; triggers cell cycle arrest in response to DNA damage; integrate signals from ATR and ATM; phosphorylation of CDC25A to delay cell cycle progression following DNA double-strand breaks. | Cal27, HN30, HN31, SCC61, UMSCC17A | N/A | Head and neck cancer | [47] |
GATA2 | 3q21.3 | Zinc-finger transcription factor; regulate transcription genes. | A549, H226, HL7702 | A549 xenograft mouse | Lung cancer | [48] |
KRAS | 12p12.1 | Transcriptional activator that regulates endothelial cells endothelin-1 gene expression. | A549, H441 | A549 xenograft mouse | Lung cancer | |
MRE11 | 11q21 | MRN complex component; DNA double-strand breaks repair via nonhomologous end-joining and homologous recombination activation in ATM-mediated checkpoint. | V-C8 | N/A | N/A | [51] |
MYC | 8q24.21 | Regulate cell cycle progression, transcription, and apoptosis. | Kelly, BE-2C, NLF, SK-N-AS, SHEP, MYCN-ER | BALB/c nude mouse | Neuroblastoma | |
NBN | 8q21.3 | MRN complex component; DNA double-strand breaks repair via nonhomologous end-joining and homologous recombination activation in ATM-mediated checkpoint. | B220, Gr-1, Mac-1 | Nbn-mutated mouse | Leukemia | [54] |
PAK3 | Xq23 | Serine-threonine protein kinase; regulates cell cycle, cell migration, and apoptosis. | CaSki, HeLa, HFK, SiHa | N/A | Cervical cancer | [55] |
PARP1 | 1q41.42 | Regulate cell proliferation and differentiation; repair DNA single- and double-strand breaks. | DLD-1, HEK293FT, KB1P-G3, KB2P, SUM149PT, U2OS | BRCA2-mutated mouse | Breast and ovarian cancer | [56] |
PLK1 | 16p12.2 | Serine-threonine protein kinase; regulate cell proliferation and apoptosis; triggers G2/M transition. | A549, H441, H522, T29 | BALB/c and C57BL/6 nude mouse | Lung cancer | [57] |
RAD50 | 5q31.1 | MRN complex component; DNA double-strand breaks repair via nonhomologous end-joining and homologous recombination activation in ATM-mediated checkpoint. | D1241, L1240, Q1262, WT | N/A | Metastatic small cell cancer | [58] |
RAD51 | 15q15.1 | Repair DNA double-strand breaks via homologous recombination. | HeLa, K562, M059, U2OS | N/A | N/A | [59] |
TP53 | 17p13.1 | Major tumor suppressor; regulate cell cycle, senescence, and apoptosis. | C4-2, LNCaP, U2OS | NSG mouse | Prostate cancer | |
53BP1 | 15q15.3 | Repair DNA double-strand breaks by promoting non-homologous end-joining pathways while limiting homologous recombination. | DOHH2, G452, HCC1187 OCI-LY (1, 8, 19), SUDHL-6, U2932, VAL | NOD, NSG, and SCID mouse | Lymphoma | |
WEE1 | 11p15.4 | Serine-threonine protein kinase; regulates G2/M checkpoint via CDC2 inhibition. | MCF7, MDA-MB-231, T-47D, Zr-75-1 | Breast cancer xenograft NSG mouse | Breast cancer | [64] |